期刊文献+

慢病毒载体介导PAX6沉默引起HLE-B3细胞凋亡

Lentiviral vector-mediated PAX6 silence induce human lens epithelial cell apoptosis
下载PDF
导出
摘要 目的:观察PAX6基因沉默后人晶状体上皮细胞系(HLE-B3)增殖的改变。方法:分别将4组PAX6 shRNA慢病毒载体及对照组慢病毒(pGCL-GFP-shRP1,2,3,4,NC)感染B3细胞;感染96h后,利用Real-time PCR和Western-blot检测B3细胞PAX6表达以确定PAX6沉默;选取有效沉默PAX6基因的pGCL-GFP-shRP4感染B3细胞,MOI=10,观察细胞数量变化。感染48h后采用流式细胞仪检测B3细胞凋亡情况。结果:感染RNAi病毒组的B3细胞,随感染时间延长,细胞数量减少。流式细胞仪检测结果显示沉默PAX648h的B3细胞,G1/G0期前出现凋亡峰。结论:慢病毒介导的RNA干扰能有效沉默B3细胞的PAX6表达;PAX6基因沉默后B3细胞凋亡。 AIM: To observe human lens epithelial cells proliferation changes when the PAX6 gene knocked-down. (HLE-B3) has been METHODS: Four groups PAX6 shRNA lentiviral vectors and the control group lentiviral ( pGCL-GFP-shRP1,2, 3, 4, NC) infect B3 cells. Real Time PCR and Western blot analysis was used to determine PAX6 silence after infection 96 hours. Effective PAX6-silence pGCL-GFP- shRP4 was selected to infect B3 cells, MOI ( Multiplicity of infection) = 10 and the changes were observed in the number of the cells. The B3 cells apoptosis was detect by flow cytometry after 48 hours in infection. .RESULTS: RNAi-virus-infected B3 cells decreased in the number of cells with infection prolonged. The flow cytometry results showed that after knock- down the PAX6 for 48 hours, apoptotic peak appeared before the G1/G0 phase. CONCLUSION : Lentivirus- mediated RNA interference can effectively silence PAX6 expression in B3 cells. There is HLE-B3 apoptosis after PAX6 aene knock-down.
出处 《国际眼科杂志》 CAS 2013年第2期256-259,共4页 International Eye Science
基金 国家自然科学基金面上项目(No.30973272)~~
关键词 慢病毒 PAX6 细胞凋亡 lentivirus PAX6 apoptosis
  • 相关文献

参考文献15

  • 1Gehring WJ,Ikeo K. Pax 6:mastering eye morphogenesis and eye evolution[J].Trends in Genetics,1999,(09):371-377.
  • 2Graw J. Eye development[J].Current Topics in Developmental Biology,2010.343-386.
  • 3Dansault A,David G,Schwartz C. Three new PAX6 mutations including one causing an unusual ophthalmic phenotype associated with neurodevelopmental abnormalities[J].Molecular Vision,2007.511-523.
  • 4Hanson IM. PAX6 and Congenital Eye Malformations[J].Pediatric Research,2003,(06):791-796.
  • 5Chien YH,Huang HP,Hwu WL. Eye anomalies and neurological manifestations in patients with PAX6 mutations[J].Molecular Vision,2009.2139-2145.
  • 6Kumar K,Tanwar M,Naithani P. PAX6 gene analysis in irido-fundal coloboma[J].Molecular Vision,2011.1414-1419.
  • 7Kokotas H,Petersen MB. Clinical and molecular aspects of aniridia[J].Clinical Genetics,2010.409-420.
  • 8Ramaesh K,Ramaesh T,Dutton GN. Evolving concepts on pathogenic mechanisms of aniridia related keratopathy[J].International Journal of Biochemistry & Cell Biology,2005,(03):547-557.
  • 9Vincent MC,Pujo AL,Olivier D. Screening for PAX6 gene mutations is consistent with haploinsufficiency as the main mechanism leading to various ocular defects[J].European Journal of Human Genetics,2003,(02):163-169.
  • 10Ioanna T,Ian MSW,Isabel MH. PAX6 mutations:genotype-phenotype correlations[J].BMC Genetics,2005,(01):27.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部